Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Itraconazole as a Targeted Therapy for Inhibiting Hedgehog Pathway Signaling in Esophageal Cancer Patients

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT02749513
Recruitment Status : Recruiting
First Posted : April 25, 2016
Last Update Posted : February 15, 2019
Sponsor:
Information provided by (Responsible Party):
David Wang, Dallas VA Medical Center